Protective effect of probiotics on Salmonella infectivity assessed with combined in vitro gut fermentation-cellular models

BMC Microbiology

Volumn 11, Issue , 2011, Pages

  Zihler, Annina ^a   Gagnon, Mélanie ^a   Chassard, Christophe ^a   Lacroix, Christophe ^a  

^a ETH ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

INULIN; MICROCIN B17; PROBIOTIC AGENT; THERMOPHILICIN B67; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL CELL; BACTERIAL GROWTH; BACTERIUM ADHERENCE; BACTERIUM CULTURE; BIFIDOBACTERIUM; BIFIDOBACTERIUM THERMOPHILUM; CELL STRAIN HT29; CONFOCAL MICROSCOPY; DRUG EFFECT; ELECTRIC RESISTANCE; EPITHELIUM CELL; ESCHERICHIA COLI; FERMENTATION; IN VITRO STUDY; IN VIVO STUDY; LARGE INTESTINE; MONOLAYER CULTURE; NONHUMAN; SALMONELLA TYPHIMURIUM; SALMONELLOSIS; TIGHT JUNCTION; BACTERIAL COUNT; BIOLOGICAL MODEL; BIOREACTOR; CELL CULTURE; CHILD; COLON; GROWTH, DEVELOPMENT AND AGING; HUMAN; IMPEDANCE; METAGENOME; MICROBIOLOGY;

BIFIDOBACTERIUM THERMOPHILUM; ESCHERICHIA COLI; SALMONELLA; SALMONELLA TYPHIMURIUM;

BIFIDOBACTERIUM; BIOREACTORS; CELLS, CULTURED; CHILD; COLON; COLONY COUNT, MICROBIAL; ELECTRIC IMPEDANCE; ESCHERICHIA COLI; FERMENTATION; HT29 CELLS; HUMANS; METAGENOME; MODELS, BIOLOGICAL; PROBIOTICS; SALMONELLA INFECTIONS; SALMONELLA TYPHIMURIUM; TIGHT JUNCTIONS;

EID: 83455225495     PISSN: None     EISSN: 14712180     Source Type: Journal    
DOI: 10.1186/1471-2180-11-264     Document Type: Article

References (47)

1. Impact of the intestinal microbiota on the development of mucosal defense. Gaskins HR, Croix JA, Nakamura N, Nava GM, Clin Infect Dis 2008 46 Suppl 2 80 S86 discussion S144-S151 18181729
2. Lactobacillus acidophilus LA 1 binds to cultured human intestinal cell lines and inhibits cell attachment and cell invasion by enterovirulent bacteria. Bernet MF, Brassart D, Neeser JR, Servin AL, Gut 1994 35 483 489 10.1136/gut.35.4.483 8174985 (Pubitemid 24131244)
3. Enteric infection meets intestinal function: how bacterial pathogens cause diarrhoea. Viswanathan VK, Hodges K, Hecht G, Nat Rev Microbiol 2009 7 110 119 19116615
4. Comparative analysis of pyrosequencing and a phylogenetic microarray for exploring microbial community structures in the human distal intestine. Claesson MJ, O'Sullivan O, Wang Q, Nikkila J, Marchesi JR, Smidt H, de Vos WM, Ross RP, O'Toole PW, PLoS One 2009 4 6669 10.1371/journal.pone.0006669 19693277
5. The impact of probiotic on gut health. Collado MC, Isolauri E, Salminen S, Sanz Y, Curr Drug Metab 2009 10 68 78 10.2174/138920009787048437 19149514
6. Advances and perspectives in in vitro human gut fermentation modeling. Payne A N, Zihler A, Chassard C, Lacroix C, Trends Biotechnol 2011 doi:10.1016/j.tibtech.2011.06.2011
7. Combining the dynamic TNO-gastrointestinal tract system with a Caco-2 cell culture model: application to the assessment of lycopene and alpha-tocopherol bioavailability from a whole food. Deat E, Blanquet-Diot S, Jarrige JF, Denis S, Beyssac E, Alric M, J Agric Food Chem 2009 57 11314 11320 10.1021/jf902392a 19899761
8. Adherence and cytokine induction in Caco-2 cells by bacterial populations from a three-stage continuous-culture model of the large intestine. Bahrami B, Child MW, Macfarlane S, Macfarlane GT, Appl Environ Microbiol 2011 77 2934 2942 10.1128/AEM.02244-10 21378047
9. Immobilization of infant fecal microbiota and utilization in an in vitro colonic fermentation model. Cinquin C, Le Blay G, Fliss I, Lacroix C, Microb Ecol 2004 48 128 138 10.1007/s00248-003-2022-7 15085302 (Pubitemid 39160995)
10. New three-stage in vitro model for infant colonic fermentation with immobilized fecal microbiota. Cinquin C, Le Blay G, Fliss I, Lacroix C, FEMS Microbiol Ecol 2006 57 324 336 10.1111/j.1574-6941.2006.00117.x 16867149 (Pubitemid 44024919)
11. Comparative effects of exopolysaccharides from lactic acid bacteria and fructo-oligosaccharides on infant gut microbiota tested in an in vitro colonic model with immobilized cells. Cinquin C, Le Blay G, Fliss I, Lacroix C, FEMS Microbiol Ecol 2006 57 226 238 10.1111/j.1574-6941.2006.00118.x 16867141 (Pubitemid 44024912)
12. Glycerol induces reuterin production and decreases Escherichia coli population in an in vitro model of colonic fermentation with immobilized human feces. Cleusix V, Lacroix C, Vollenweider S, Le Blay G, FEMS Microbiol Ecol 2008 63 56 64 10.1111/j.1574-6941.2007.00412.x 18028400 (Pubitemid 350233293)
13. New in vitro colonic fermentation model for Salmonella infection in the child gut. Le Blay G, Rytka J, Zihler A, Lacroix C, FEMS Microbiol Ecol 2009 67 198 207 10.1111/j.1574-6941.2008.00625.x 19087202
14. Set up of a new in vitro model to study dietary fructans fermentation in formula-fed babies. Le Blay G, Chassard C, Baltzer S, Lacroix C, Br J Nutr 2010 103 403 411 10.1017/S0007114509991796 19751535
15. Unexpected consequences of administering bacteriocinogenic probiotic strains for Salmonella populations, revealed by an in vitro colonic model of the child gut. Zihler A, Gagnon M, Chassard C, Hegland A, Stevens MJ, Braegger CP, Lacroix C, Microbiology 2010 156 3342 3353 10.1099/mic.0.042036-0 20688827
16. In vitro inhibition activity of different bacteriocin-producing Escherichia coli against Salmonella strains isolated from clinical cases. Zihler A, Le Blay G, de Wouters T, Lacroix C, Braegger CP, Lehner A, Tischler P, Rattei T, Hachler H, Stephan R, Lett Appl Microbiol 2009 49 31 38
17. Identification of Bifidobacterium thermophilum RBL67 isolated from baby faeces and partial purification of its bacteriocin. von Ah U, PhD thesis Diss Nr 16927, Swiss Federal Institute of Technology Zurich (ETHZ), Zurich, Switzerland 2006
18. Classification of a moderately oxygen-tolerant isolate from baby faeces as Bifidobacterium thermophilum. von Ah U, Mozzetti V, Lacroix C, Kheadr EE, Fliss I, Meile L, BMC Microbiol 2007 7 79 10.1186/1471-2180-7-79 17711586 (Pubitemid 350042988)
19. Effect of probiotics on intestinal barrier function. Mennigen R, Bruewer M, Ann N Y Acad Sci 2009 1165 183 189 10.1111/j.1749-6632.2009.04059.x 19538305
20. Ecology of probiotics and enteric protection. Gagnon M, Zihler A, Chassard C, Lacroix C, Probiotic Bacteria and Enteric Infections-Cytoprotection by probiotic bacteria Springer Science + Business Media B.V., Malago JJ, Koninkx JFJG, Marinsek-Logar R, 2011 1 65 85
21. Differential early interactions between Salmonella enterica serovar Typhi and two other pathogenic Salmonella serovars with intestinal epithelial cells. Weinstein DL, O'Neill BL, Hone DM, Metcalf ES, Infect Immun 1998 66 2310 2318 9573122 (Pubitemid 28194135)
22. Guidance for substantiating the evidence for beneficial effects of probiotics: impact of probiotics on digestive system metabolism. Rabot S, Rafter J, Rijkers GT, Watzl B, Antoine JM, J Nutr 2010 140 677S 689S 10.3945/jn.109.113738 20107147
23. Probiotic colonization of the adherent mucus layer of HT29MTXE12 cells attenuates Campylobacter jejuni virulence properties. Alemka A, Clyne M, Shanahan F, Tompkins T, Corcionivoschi N, Bourke B, Infect Immun 2010 78 2812 2822
24. Functional cell models of the gut and their applications in food microbiology - a review. Cencic A, Langerholc T, Int J Food Microbiol 2010 141 Suppl 1 4 S14 20444515
25. Induction of cytokine formation by human intestinal bacteria in gut epithelial cell lines. Bahrami B, Macfarlane S, Macfarlane GT, J Appl Microbiol 2011 110 353 363 10.1111/j.1365-2672.2010.04889.x 21070518
26. Potential benefits of pro- and prebiotics on intestinal mucosal immunity and intestinal barrier in short bowel syndrome. Stoidis CN, Misiakos EP, Patapis P, Fotiadis CI, Spyropoulos BG, Nutr Res Rev 2010 1 9
27. Short chain fatty acids influence virulence properties of Salmonella enterica serovar Typhimurium. Rishi P, Pathak S, Ricke SC, J Environ Sci Health B 2005 40 645 657 10.1081/PFC-200061576 16047886 (Pubitemid 40995192)
28. Probiotic bacteria influence the composition and function of the intestinal microbiota. O'Toole PW, Cooney JC, Interdiscip Perspect Infect Dis 2008 2008 175285 19277099
29. Chapter 1 Understanding the mechanisms by which probiotics inhibit gastrointestinal pathogens. Corr SC, Hill C, Gahan CG, Adv Food Nutr Res 2009 56 1 15 19389605
30. Guidance for substantiating the evidence for beneficial effects of probiotics: prevention and management of allergic diseases by probiotics. Kalliomaki M, Antoine JM, Herz U, Rijkers GT, Wells JM, Mercenier A, J Nutr 2010 140 713S 721S 10.3945/jn.109.113761 20130079
31. Effect of fecal water on an in vitro model of colonic mucosal barrier function. Gill CI, Heavey P, McConville E, Bradbury I, Fassler C, Mueller S, Cresci A, Dore J, Norin E, Rowland I, Nutr Cancer 2007 57 59 65 10.1080/01635580701268220 17516863 (Pubitemid 46871570)
32. Short-chain fatty acids affect cell-association and invasion of HEp-2 cells by Salmonella typhimurium. Durant JA, Lowry VK, Nisbet DJ, Stanker LH, Corrier DE, Ricke SC, J Environ Sci Health B 1999 34 1083 1099 10.1080/03601239909373246 10565427
33. Unveiling an abundant core microbiota in the human adult colon by a phylogroup-independent searching approach. Sekelja M, Berget I, Naes T, Rudi K, ISME J 2011 5 519 531 10.1038/ismej.2010.129 20740026
34. Probiotic colonization of the adherent mucus layer of HT29MTXE12 cells attenuates Campylobacter jejuni virulence properties. Alemka A, Clyne M, Shanahan F, Tompkins T, Corcionivoschi N, Bourke B, Infect Immun 2010 78 2812 2822 10.1128/IAI.01249-09 20308300
35. Rapid disruption of epithelial barrier function by Salmonella typhimurium is associated with structural modification of intercellular junctions. Jepson MA, Collares-Buzato CB, Clark MA, Hirst BH, Simmons NL, Infect Immun 1995 63 356 359 7806378
36. Functional modulation of enterocytes by gram-positive and gram-negative microorganisms. Otte JM, Podolsky DK, Am J Physiol Gastrointest Liver Physiol 2004 286 613 G626 10.1152/ajpgi.00341.2003 15010363
37. Live probiotics protect intestinal epithelial cells from the effects of infection with enteroinvasive Escherichia coli (EIEC). Resta-Lenert S, Barrett KE, Gut 2003 52 988 997 10.1136/gut.52.7.988 12801956 (Pubitemid 36765291)
38. Probiotic bacteria enhance murine and human intestinal epithelial barrier function. Madsen K, Cornish A, Soper P, McKaigney C, Jijon H, Yachimec C, Doyle J, Jewell L, De Simone C, Gastroenterology 2001 121 580 591 10.1053/gast.2001.27224 11522742 (Pubitemid 32822573)
39. Adhesion of bile-adapted Bifidobacterium strains to the HT29-MTX cell line is modified after sequential gastrointestinal challenge simulated in vitro using human gastric and duodenal juices. de Los Reyes-Gavilan CG, Suarez A, Fernandez-Garcia M, Margolles A, Gueimonde M, Ruas-Madiedo P, Res Microbiol 2011 162 514 519 10.1016/j.resmic.2011.03.009 21419219
40. Salmonella host cell invasion emerged by acquisition of a mosaic of separate genetic elements, including Salmonella pathogenicity island 1 (SPI1), SPI5, and sopE2. Mirold S, Ehrbar K, Weissmuller A, Prager R, Tschape H, Russmann H, Hardt WD, J Bacteriol 2001 183 2348 2358 10.1128/JB.183.7.2348-2358. 2001 11244077 (Pubitemid 32240407)
41. Effects of butyrate on intestinal barrier function in a Caco-2 cell monolayer model of intestinal barrier. Peng L, He Z, Chen W, Holzman IR, Lin J, Pediatr Res 2007 61 37 41 10.1203/01.pdr.0000250014.92242.f3 17211138 (Pubitemid 46352313)
42. Production of antibacterial substances by bifidobacterial isolates from infant stool active against Listeria monocytogenes. Touré R, Kheadr E, Lacroix C, Moroni O, Fliss I, J Appl Microbiol 2003 95 1058 1069 10.1046/j.1365-2672.2003.02085.x 14633035 (Pubitemid 37357389)
43. Measurement of gastrointestinal pH and regional transit times in normal children. Fallingborg J, Christensen LA, Ingeman-Nielsen M, Jacobsen BA, Abildgaard K, Rasmussen HH, Rasmussen SN, J Pediatr Gastroenterol Nutr 1990 11 211 214 10.1097/00005176-199008000-00010 2395061 (Pubitemid 20225906)
44. Colonic transit time - what is normal? Wagener S, Shankar KR, Turnock RR, Lamont GL, Baillie CT, J Pediatr Surg 2004 39 166 169 discussion 166-169 10.1016/j.jpedsurg.2003.10.002 14966733 (Pubitemid 38146430)
45. Growth adaptation to methotrexate of HT-29 human colon carcinoma cells is associated with their ability to differentiate into columnar absorptive and mucus-secreting cells. Lesuffleur T, Barbat A, Dussaulx E, Zweibaum A, Cancer Res 1990 50 6334 6343 2205381 (Pubitemid 20323697)
46. Polycyclic aromatic hydrocarbon release from a soil matrix in the in vitro gastrointestinal tract. Van de Wiele TR, Verstraete W, Siciliano SD, J Environ Qual 2004 33 1343 1353 10.2134/jeq2004.1343 15254116 (Pubitemid 38970893)
47. Enterobacter sakazakii invasion in human intestinal Caco-2 cells requires the host cell cytoskeleton and is enhanced by disruption of tight junction. Kim KP, Loessner MJ, Infect Immun 2008 76 562 570 10.1128/IAI.00937-07 18070906 (Pubitemid 351251726)